Olsson B - Search Results

1

In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.

Byron PR, Hindle M, Lange CF, Longest PW, McRobbie D, Oldham MJ, Olsson B, Thiel CG, Wachtel H, Finlay WH. Byron PR, et al. Among authors: olsson b. J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S59-69. doi: 10.1089/jamp.2010.0846. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 21133801 Review.

2

Introduction. 1000 years of pharmaceutical aerosols: what remains to be done?

Borgström L, Clark A, Olsson B. Borgström L, et al. Among authors: olsson b. J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S1-4. doi: 10.1089/jamp.2010.0848. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 21133797 No abstract available.

3

Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary Disposition.

Bäckman P, Tehler U, Olsson B. Bäckman P, et al. Among authors: olsson b. J Aerosol Med Pulm Drug Deliv. 2017 Apr;30(2):108-117. doi: 10.1089/jamp.2016.1306. Epub 2016 Oct 14. J Aerosol Med Pulm Drug Deliv. 2017. PMID: 27740878 Clinical Trial.

4

Validation of a general in vitro approach for prediction of total lung deposition in healthy adults for pharmaceutical inhalation products.

Olsson B, Borgström L, Lundbäck H, Svensson M. Olsson B, et al. J Aerosol Med Pulm Drug Deliv. 2013 Dec;26(6):355-69. doi: 10.1089/jamp.2012.0986. Epub 2013 Feb 19. J Aerosol Med Pulm Drug Deliv. 2013. PMID: 23421897 Clinical Trial.

5

On the Validation of Generational Lung Deposition Computer Models Using Planar Scintigraphic Images: The Case of Mimetikos Preludium.

Olsson B, Kassinos SC. Olsson B, et al. J Aerosol Med Pulm Drug Deliv. 2021 Apr;34(2):115-123. doi: 10.1089/jamp.2020.1620. Epub 2020 Aug 13. J Aerosol Med Pulm Drug Deliv. 2021. PMID: 32790531

6

Degree of throat deposition can explain the variability in lung deposition of inhaled drugs.

Borgström L, Olsson B, Thorsson L. Borgström L, et al. Among authors: olsson b. J Aerosol Med. 2006 Winter;19(4):473-83. doi: 10.1089/jam.2006.19.473. J Aerosol Med. 2006. PMID: 17196076

7

Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler.

Borgström L, Asking L, Beckman O, Bondesson E, Källén A, Olsson B. Borgström L, et al. Among authors: olsson b. J Aerosol Med. 1998;11 Suppl 1:S59-64. J Aerosol Med. 1998. PMID: 10180734 No abstract available.

8

Studies of the human oropharyngeal airspaces using magnetic resonance imaging IV--the oropharyngeal retention effect for four inhalation delivery systems.

Burnell PK, Asking L, Borgström L, Nichols SC, Olsson B, Prime D, Shrubb I. Burnell PK, et al. Among authors: olsson b. J Aerosol Med. 2007 Fall;20(3):269-81. doi: 10.1089/jam.2007.0566. J Aerosol Med. 2007. PMID: 17894534

9

Dose delivery late in the breath can increase dry powder aerosol penetration into the lungs.

Bondesson E, Bengtsson T, Borgström L, Nilsson LE, Norrgren K, Olsson B, Svensson M, Wollmer P. Bondesson E, et al. Among authors: olsson b. J Aerosol Med. 2005 Spring;18(1):23-33. doi: 10.1089/jam.2005.18.23. J Aerosol Med. 2005. PMID: 15741771 Clinical Trial.

10

Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: Design.

Marple VA, Roberts DL, Romay FJ, Miller NC, Truman KG, Van Oort M, Olsson B, Holroyd MJ, Mitchell JP, Hochrainer D. Marple VA, et al. Among authors: olsson b. J Aerosol Med. 2003 Fall;16(3):283-99. doi: 10.1089/089426803769017659. J Aerosol Med. 2003. PMID: 14572326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters